Symbols

SXTC

China SXT Pharmaceuticals·NASDAQ

--(--)

7.59 / 10

Outperform

Analyst input is unavailable (ana_eval = -1). Fund‑flow analysis rates the stock 7.59/10, labeling it ‘good’, yet all size‑segment trends are negative despite modest inflow ratios (~0.44). The flow picture is mixed, with decent liquidity but bearish sentiment.

Fund Flow Rating

What is the market sentiment for SXTC?

SXTC holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.59/10 (Outperform).